
Would you like to receive update from CareSync Experts?
Summary, notice description and lot information
The NHS Greater Manchester Integrated Care Board has announced the intention to award a contract for Intravenous Therapy and Bisphosphonates services, classified under Community Health Services (CPV 85323000). The procurement process is at the award stage and involves a limited procurement method under the Provider Selection Regime (PSR). 87, is set to commence on 1st April 2024 and run until 30th September 2025.
It aims to provide IV therapy services to medically stable patients aged 16 and over, registered with Stockport GP Practice, either at home or in a community healthcare setting. Representations by providers must be made by 22nd April 2025, marking the end of the standstill period. This tender presents a significant opportunity for businesses specialising in community health services and IV therapy.
The contract's emphasis on quality, innovation, collaboration, and social value, along with its substantial financial value, would be particularly appealing to large healthcare providers like Mastercall Healthcare, which has been named the intended supplier. Companies with expertise in delivering home-based healthcare services and those capable of integrating health services to improve access and reduce inequalities would be well-suited to compete and benefit from such contracts, fostering business growth and expanding their service portfolios.
The IV Therapy service enables patients (aged 16+ registered with Stockport GP Practice) who are medically stable, to safely receive IV therapy in their own homes or in a community health care setting. This contract will be for 18-months from 1st April 2024 to 30th September 2025. The total value of this contract will be PS1,120,224,87. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of The Procurement Act 2023 Regulations do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight on 22nd April 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: nhsgm.procurement@nhs.net Key Award Criteria - Quality and innovation - 20%, Value 25%, Integration, collaboration and service sustainability - 25%, improving access, reducing health inequalities and facilitating choice - 20% and Social Value - 10%. Award decision-makers: Corporate Director of Finance - Commissioning & Financial Assurance and the Executive Committee on behalf on NHS Greater Manchester Integrated Care Board. No conflicts of interest were declared.
Notice type, method, and CPV codes
Financial information and value estimates
Contract duration information not available.
Publication, submission, and award timeline
Current status of tender, lots, awards, and contracts
Buyer organisation and contact details
Supplier who was awarded this contract
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact Us